Publications by authors named "Jyrki T Jalkanen"
Article Synopsis
- - This study evaluated the impact of pelvic organ prolapse (POP) surgery on stress urinary incontinence (SUI), focusing on symptom changes, follow-up procedures, and factors influencing outcomes in patients without prior SUI surgery.
- - Out of 2,677 surgeries analyzed, about 50% initially reported SUI symptoms, with significant improvements noted post-surgery, though 20% developed new SUI symptoms afterwards.
- - Key findings showed that higher baseline symptom severity raised the likelihood of persistent SUI, while certain factors, like age and prior urgency urinary incontinence, were linked to developing new SUI symptoms following the surgery.
Introduction And Hypothesis: It is unclear how compartment of pelvic organ prolapse (POP) impacts overactive bladder (OAB) symptom severity or improvement after POP surgery. We hypothesized that anterior and apical prolapse are more strongly associated with OAB symptoms than posterior compartment prolapse.
Methods: A total of 2933 POP surgeries from a prospective population-based cohort were divided into two groups: (1) anterior and/or apical compartment surgery (± posterior repair), N = 2091; (2) posterior repair only, N = 478.
Introduction And Hypothesis: Patient-reported outcome measures are fundamental tools when assessing effectiveness of treatments. The challenge lies in the interpretation: which magnitude of change in score is meaningful for the patients? The minimal important difference (MID) is defined as the smallest difference in score that patients perceive as important. The Patient Acceptable Symptom State (PASS) represents the value of score beyond which patients consider themselves well.
View Article and Find Full Text PDFBackground: Defecation symptoms are common among women with pelvic organ prolapse. However, the relationship between posterior vaginal wall prolapse and defecation symptoms remains debatable. Even though there is a plausible biomechanical rationale for posterior wall prolapse to cause obstructed defecation, previous studies have drawn contradictory conclusions regarding the association.
View Article and Find Full Text PDFObjective: To determine the feasibility and efficacy of sequential gemcitabine-carboplatin followed by paclitaxel-carboplatin in the first-line treatment of advanced epithelial ovarian cancer, with the response rate as the primary endpoint.
Methods: After primary laparotomy, 56 patients with FIGO Stages III-IV disease were given 4 cycles of gemcitabine 1000 mg/m2 d1,8 and carboplatin AUC5 (44 patients) or AUC6 (12 patients) d1 q3wk followed by 4 cycles of paclitaxel 175 mg/m2 d1 and carboplatin AUC5/6 q3wk. Of the tumors, 43 were serous, 6 clear cell, 4 endometrioid, and 3 anaplastic type.